Market Place
Sourcing Support
Context Therapeutics Appoints Two New Board Members
04 Sep 2024 //
GLOBENEWSWIRE
Subcutaneous Trastuzumab Proves Safe and Tolerable in HER2+ MBC
28 Aug 2023 //
ONCLIVE
Keytruda combination hits primary endpoint in a rare form of gastric cancer
17 Jun 2023 //
YAHOO FINANCE
Long-term Ph3 Results Show Similar Efficacy, Cardiac Safety of SB3 vs Herceptin
06 May 2023 //
CENTERFORBIOSIMILARS
‘EMA’s refusal to authorize Herceptin biosimilar unfair’
23 May 2022 //
KOREABIOMED
Result of Phase 3 Study for Prestige’s HD201 Published in JAMA Oncology
11 Mar 2022 //
BUSINESSWIRE
BMS` Opdivo hits more approvable goal in early NSCLC
09 Nov 2021 //
SEEKINGALPHA
Seagen undaunted by AstraZeneca-Daiichi`s Enhertu
30 Oct 2021 //
FIERCEPHARMA
GSK`s Shingrix rebound has yet to materialize, analysts say
16 Sep 2021 //
FIERCEPHARMA
ESMO: Zymeworks lays down marker in fight to unseat Herceptin
16 Sep 2021 //
FIERCEBIOTECH
MacroGenics wins breast cancer nod with Herceptin-topping data
18 Dec 2020 //
FIERCE PHARMA
CHMP recommends EU approval of Roche’s Phesgo (fixed-dose combination of Perjeta
13 Nov 2020 //
PRESS RELEASE
China approves its first biosimilar of Roche`s Herceptin in HER2+ cancers
18 Aug 2020 //
PHARMAFILE
Genentech, Amgen Settle Herceptin, Avastin Biosimilar Disputes
09 Jul 2020 //
BIGMOLECULEWATCH
FDA Approvals Roundup: Fintepla, Dojolvi, Phesgo
02 Jul 2020 //
RAPS
Roche wards off Herceptin copycats with Perjeta combo product
01 Jul 2020 //
FIERCE PHARMA
Clinical Data of Avifavir to Become Available to International Partners
29 Jun 2020 //
PRNEWSWIRE
Health Canada Issues Hoffman-La Roche Herceptin Product Recall
29 Jun 2020 //
HEALTH CANADA
Seattle Genetics breaks into breast cancer with new approval Tukysa
18 Apr 2020 //
FIERCE PHARMA
Merck, Samsung join newly crowded market for Herceptin biosimilars
16 Apr 2020 //
BIOPHARMADIVE
Russian Pharma Company Biocad Obtains European Certification for Biosimilars
02 Apr 2020 //
BIGMOLECULEWATCH
US Biosimilar Launches About to Turn a Corner
16 Mar 2020 //
RAPS
Halozyme Announces FDA Has Accepted BLA For Fixed-Dose Subcutaneous Combination
25 Feb 2020 //
PR NEWSWIRE
Pfizer hits its biosimilar stride
28 Jan 2020 //
BIOPHARMADIVE
EMA backs adjuvant use of Roche’s breast cancer ADC Kadcyla
18 Dec 2019 //
PMLIVE
NeuClone Announces Positive Results from Phase I Study of Herceptin
05 Dec 2019 //
BUSINESSWIRE
Roche`s Herceptin faces second U.S. biosim after Mylan launch
03 Dec 2019 //
FIERCE BIOTECH
Genentech to Present Data for 7 Approved Medicines for Multi Type Breast Cancer
17 Nov 2019 //
BUSINESS WIRE
Seattle Genetics` breast cancer drug hits mark in pivotal trial
21 Oct 2019 //
FIERCE BIOTECH
Roche limits biosim damage to cancer blockbusters, but it`s still early
17 Oct 2019 //
FIERCE PHARMA
Biosimilars will leave a $10B gap in Roche`s sales: exec
19 Sep 2019 //
FIERCE PHARMA
Biosimilars will leave a $10B gap in Roche`s sales: exec
18 Sep 2019 //
FIERCE PHARMA
Roche’s fixed-dose subcutaneous combination of Perjeta & Herceptin
13 Sep 2019 //
PRESS RELEASE
Roche preps filings for Herceptin/Perjeta combination
13 Sep 2019 //
PMLIVE
Henlius Biotech shrugs off Hong Kong disruption with $477M IPO bid
13 Sep 2019 //
PHARMAPHORUM
Roche`s Tecentriq, on an EU hot streak, bags 2 new lung cancer approvals
07 Sep 2019 //
FIERCEPHARMA
Genentech settles fight over cancer drug trade secrets with Taiwan`s JHL
06 Sep 2019 //
FIERCEPHARMA
Chugai seeks new Kadcyla indication in Japan
30 Aug 2019 //
THE PHARMALETTER
The top 10 franchise drugs in biopharma history will earn $1.4T (trillion)
16 Aug 2019 //
ENDPTS
Herceptin drops on contracting ahead of US biosim, but Roche sales stomp anyway
24 Jul 2019 //
FIERCE PHARMA
Unum Plunges After FDA Places Another Clinical Hold on Company Asset
04 Jul 2019 //
BIOSPACE
Mundipharma picks up rights to Herceptin biosimilar Tuznue
02 Jul 2019 //
PHARMATIMES
Pfizer`s Avastin biosimilar wins FDA approval
28 Jun 2019 //
REUTERS
FDA greenlights Herceptin copycat from Amgen, Allergan
18 Jun 2019 //
ENDPTS
FDA Approves 20th Biosimilar, 5th for Roche’s Herceptin
14 Jun 2019 //
RAPS
Roche touts phase 2 Gazyva data in lupus patients
12 Jun 2019 //
FIERCE PHARMA
Roche snags first-in-class FDA nod for lymphoma drug Polivy
11 Jun 2019 //
FIERCE PHARMA
Pfizer To Launch Several Drugs Despite Generic Headwinds
05 Jun 2019 //
BIOSIMILAR DEVELOPMENT
Biocon and Mylan get Canadian nod for biosimilar cancer drug Ogivri
23 May 2019 //
BUSINESS-STANDARD
Puma Biotech cancer launch Nerlynx suffered in Q1.
10 May 2019 //
FIERCE PHARMA
Roche`s Ocrevus discount wins over England`s cost watchdogs
10 May 2019 //
FIERCE PHARMA
Novartis`s Sandoz strikes deal for biosimilar of Herceptin
01 May 2019 //
REUTERS
FDA approves Pfizer`s biosimilar to Roche`s Herceptin
12 Mar 2019 //
REUTERS
Roche receives US FDA approval for Herceptin Hylecta for subcutaneous injection
01 Mar 2019 //
PHARMABIZ
Samsung Bioepis biosimilar to Roche`s Herceptin wins FDA nod
19 Jan 2019 //
REUTERS
Samsung Bioepis biosimilar to Roche`s Herceptin wins FDA nod
18 Jan 2019 //
REUTERS
Roche`s Tecentriq wins speedy U.S. FDA review for small cell lung cancer
05 Dec 2018 //
REUTERS
Spotlight on drug pricing could change in US biosimilar landscape
01 Dec 2018 //
ENDPTS
Genentech claims Sanofi partner used stolen trade secrets to develop rival drugs
09 Nov 2018 //
ENDPTS
